(Q41349081)

29 September 2017

1 reference

title

Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions (English)

1 reference

29 September 2017

1 reference

R G Vile

1

1 reference

PubMed ID

9034596

29 September 2017

H Chong

series ordinal

2

1 reference

29 September 2017

1 September 1996

1 reference

Cancer and Metastasis Reviews

29 September 2017

1 reference

29 September 2017

15

1 reference

29 September 2017

3

1 reference

29 September 2017

351-364

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00046347

29 September 2017

0 references

cites work

Interleukin 12: a new clinical player in cytokine therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00046347

Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy

21 January 2018

1 reference

12 December 2020

Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells

1 reference

12 December 2020

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

1 reference

12 December 2020

Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.

1 reference

12 December 2020

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

12 December 2020

A new look for the 1990s

1 reference

12 December 2020

MHC antigens and cancer: implications for T-cell surveillance

1 reference

12 December 2020

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

12 December 2020

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

12 December 2020

Experimental and clinical studies of cytokine gene-modified tumor cells

1 reference

12 December 2020

Stimulatory effects of immune reactions upon the growths of untransplanted tumors.

1 reference

12 December 2020

Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

1 reference

12 December 2020

Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity.

1 reference

12 December 2020

Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

1 reference

12 December 2020

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

12 December 2020

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

12 December 2020

Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.

1 reference

12 December 2020

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

1 reference

12 December 2020

Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

1 reference

12 December 2020

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

1 reference

12 December 2020

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

12 December 2020

The dendritic cell system and its role in immunogenicity

1 reference

12 December 2020

Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.

1 reference

12 December 2020

A genetic approach to idiotypic vaccination

1 reference

12 December 2020

Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines

1 reference

12 December 2020

Cancer antigens: immune recognition of self and altered self

1 reference

12 December 2020

Lymphocyte responses and cytokines

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor

1 reference

12 December 2020

Gene transfer technologies for the gene therapy of cancer

1 reference

12 December 2020

Th1 and Th2 subsets: paradigms lost?

1 reference

12 December 2020

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

1 reference

12 December 2020

Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir

1 reference

12 December 2020

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Viral vector systems for gene therapy.

1 reference

12 December 2020

Apoptosis (the 1992 Frank Rose Memorial Lecture).

1 reference

12 December 2020

Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma

1 reference

12 December 2020

Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

1 reference

12 December 2020

IL2 treatment for cancer: from biology to gene therapy

1 reference

12 December 2020

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

12 December 2020

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

12 December 2020

Apoptosis in cancer therapy: crossing the threshold

1 reference

12 December 2020

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Exposing the immunology of naked DNA vaccines.

1 reference

12 December 2020

Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult.

1 reference

12 December 2020

Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.

1 reference

12 December 2020

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

1 reference

12 December 2020

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

12 December 2020

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant

1 reference

12 December 2020

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

1 reference

12 December 2020

Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and g

1 reference

12 December 2020

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

12 December 2020

Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

1 reference

12 December 2020

Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.

1 reference

12 December 2020

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

1 reference

12 December 2020

Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?

1 reference

12 December 2020

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma

1 reference

12 December 2020

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

1 reference

12 December 2020

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo

1 reference

12 December 2020

Cancer vaccines: the interleukin 2 dosage effect

1 reference

12 December 2020

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

12 December 2020

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

1 reference

12 December 2020

Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.

1 reference

12 December 2020

Two competing influences that may explain concomitant tumor resistance.

1 reference

12 December 2020

'Bystander killing' induces apoptosis and is inhibited by forskolin

1 reference

12 December 2020

5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.

1 reference

12 December 2020

Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity

1 reference

12 December 2020

Antigenic cancer cells that escape immune destruction are stimulated by host cells

1 reference

12 December 2020

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

12 December 2020

B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

12 December 2020

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1 reference

12 December 2020

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

1 reference

12 December 2020

Tumor-specific gene expression

1 reference

12 December 2020

Targeted vectors for gene therapy.

1 reference

12 December 2020

Identification of human cancers deficient in antigen processing

1 reference

12 December 2020

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

1 reference

12 December 2020

Specificity and longevity of antitumor immune responses induced by B7-transfected tumors

1 reference

12 December 2020

Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells

1 reference

12 December 2020

Molecular approaches to cancer immunotherapy

1 reference

12 December 2020

Cell biology of antigen presentation

1 reference

12 December 2020

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

12 December 2020

An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast-cancer model.

1 reference

12 December 2020

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

1 reference

12 December 2020

Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir

1 reference

12 December 2020

The case for therapeutic vaccines.

1 reference

12 December 2020

Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype

1 reference

12 December 2020

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA

1 reference

12 December 2020

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells

1 reference

12 December 2020

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

12 December 2020

Immunization by direct DNA inoculation induces rejection of tumor cell challenge.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00046347

1 reference

PubMed ID

9034596

Dimensions Publication ID

29 September 2017

0 references

1 reference

PubMed ID

9034596